Immuno-oncology Research

Immuno-oncology research assays

We provide compliant immuno-oncology research studies to support the development of candidate drugs in accordance with regulatory requirements.

Conduct research on tumor inhibitors, cancer vaccines, oncolytic viral vectors, and adoptive T cell immunotherapy to modulate tumor immune responses. Advance new drug candidates to clinical trials through preclinical studies.

We provide immuno-oncology research services, including:

In vitro and in vivo T cell depletion models
Cytokine panels
ELISpot assays
Multicolor FACS for immune phenotyping
Cytokine panels

Cancer Immunotherapy Toxicology Studies

Conducting specific cancer immunotherapy toxicology studies using BSL-2 and BSL-3 laboratories.

Conducting GLP toxicology studies using mouse tumor models, rodents, non-rodents, or non-human primates, while utilizing BSL-2 laboratory resources. These studies include the toxicological evaluation of gene therapy viral vectors and oncolytic viral vectors, along with comprehensive bioanalytical testing.